2025 National Symposium on Bone Marrow Failure Syndromes
REGISTER NOW
Maddie Riewoldt’s Vision is thrilled to invite you to join us at the 4th National Symposium on Bone Marrow Failure Syndromes, to be held from the 23-25 May 2025 at the Victorian Comprehensive Cancer Centre in Melbourne.
Secure your spot today!
The symposium will bring together expert clinicians, scientists and allied health professionals to present innovative research on the diagnosis, treatment, patient care, and clinical trials for Bone Marrow Failure Syndromes. We are thrilled to welcome international guest speakers Dr Marcin Wlodarski and Dr Marta Derecka from St. Jude Children’s Research Hospital in Memphis, alongside over 20 national speakers who will showcase their research. The event will also offer ample opportunities for networking and collaboration.
Program Highlights
Friday May 23, 2025:
Opening Plenary & Welcome Reception
2.30 pm – 7.30 pm
(Afternoon tea, canapés, and drinks included)
Saturday May 24, 2025:
Full-Day Scientific Program
9 am – 5 pm
(Morning tea, lunch, and afternoon tea included)
Sunday May 25, 2025:
Half-Day Scientific Program
9 am – 1.30 pm
(Morning tea included)
Registration Pricing:
All Days (including Welcome Reception) – $247.50
Saturday & Sunday – $192.50
Saturday Only – $137.50
Sunday Only – $55
International guest speakers will present across all days, complemented by a balanced mix of scientific and clinical talks. The final program and speaker line-up will be announced in the coming weeks, so stay tuned!
We are thrilled to announce our invited international keynote speaker:
Dr Marcin Wlodarski, MD, PhD
Assistant Member/Prof. Department of Hematology
Director Bone Marrow Failure Program
Attending, Clinical Hematology St. Jude Children’s Research Hospital, Memphis, Tennessee, United States
Dr. Marcin Wlodarski is an Assistant Professor at St. Jude Children’s Research Hospital, where he directs the Bone Marrow Failure (BMF) and Myelodysplastic Syndromes (MDS) Program. He received his MD and PhD from Charité Medical School, Berlin, with additional training at Karolinska Institute, Stockholm. His postgraduate training included pediatrics residency and hematology/oncology fellowship at the University of Freiburg, Germany. Dr. Wlodarski’s research focuses on the genomics of inherited hematological disorders predisposing to BMF, MDS, and leukemia. His laboratory has made discoveries in genetic syndromes caused by mutations in SAMD9/SAMD9L, GATA2, RPA1, and MDM4 genes. At St. Jude, he established a comprehensive BMF/MDS program and leads innovative clinical trials.
With over 100 peer-reviewed publications, Dr. Wlodarski’s work has been recognized with awards including the Tito Bastianello Award and the Kind Philipp Prize. He chairs the US-wide registry for pediatric BMF/MDS of the North American Pediatric Aplastic Anemia Consortium. Dr. Wlodarski divides his time between clinical duties and directing a laboratory focused on the genomics of BMF syndromes.
We would like to acknowledge and extend our sincere gratitude to the following sponsors for their support and contribution towards this exciting event:
Gold Partner
Novartis
Novartis is improving the lives of more than 2.8 million patients across Australia and New Zealand through our medicines. By partnering with the healthcare system we are working for patients to address their needs, and we are committed to accelerating patient access to life saving treatments and associated healthcare.
Visit WebsiteSilver Partners
The Royal Melbourne Hospital Foundation
The Royal Melbourne Hospital is one of the largest and busiest hospitals in Australia, and our team of nearly 10,000 staff treats more than 100,000 inpatients and 200,000 outpatients each year, including more than 30,000 cancer patients. The Royal Melbourne Hospital Foundation works with individual donors, grateful consumers, companies and partner organisations in our community to support the RMH in its mission to advance health for everyone, every day.
Visit Website
Takeda
Takeda is a global, values-based, R&D-driven biopharmaceutical leader, committed to bringing Better Health and a Brighter Future to patients, by translating science into highly-innovative medicines. Takeda focuses on four therapeutic areas: Oncology, Rare Diseases, Neuroscience and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.
Visit WebsiteCatering Partner
Zouki
Zouki is a hospitality trailblazer with over thirty years of rich history, including two dedicated decades in public health. Zouki specialises in corporate catering, providing comprehensive packages for special events, extending to private residences, corporate locations, and hospitals. Discover the Zouki experience at their numerous locations throughout Victoria and across Australia.
Visit WebsiteTo find out more please contact us at – [email protected]
2023 National Symposium on Bone Marrow Failure Syndromes
Maddie Riewoldt’s Vision was proud to hold the 2023 Maddie Riewoldt’s National Symposium on Bone Marrow Failure Syndromes in Melbourne from Saturday October 14 – Sunday October 15 at the Victorian Comprehensive Cancer Centre.
Our scientific symposium included international experts Dr Sharon Savage (Clinical Director of the Division of Cancer Epidemiology and Genetics National Cancer Institute, United States) and Professor Rodrigo Calado (Chair, Department of Medical Imaging, Hematology, and Clinical Oncology Ribeirão Preto School of Medicine, University of São Paulo, Brazil), along with 28 national speakers whose presentations covered a mix of basic science, translational research, gene therapy, clinical research and patient case studies across both acquired and inherited Bone Marrow Failure Syndromes.
We were thrilled to have over 150 delegates attend across both days to learn, collaborate and network with local and international Bone Marrow Failure Syndrome experts.
“Fantastic breadth of topics (basic science, translation, gene therapy, clinical adult/paeds, immune and inherited BM, non-haem manifestations), plus a predominantly local/emerging research focus rather than a “big pharma” focus. Very collaborative meeting that fostered discussion among all attendees.
2021 National Symposium
“Excellent chairs, speakers, topics and discussions. Very thought provoking and enlightening.”
Building on the success of the 2019 Symposium, the CRE was delighted to host the 2021 National Symposium on Bone Marrow Failure Syndromes on Thursday 27 May to Saturday 29 May. Due to the pandemic, it was an entirely virtual event, incorporating a full day Patient and Family Forum and a one and a half day Scientific Symposium.
2019 National Symposium
Maddie Riewoldt’s Vision has been the only organisation in Australia prioritising research in Bone Marrow Failure Syndromes since 2016. In May 2019, Maddie’s Vision reinforced this commitment with Australia’s Inaugural National Symposium on Bone Marrow Failure Syndromes which took place across two days at the Victorian Comprehensive Cancer Centre, Melbourne. The Centre of Research Excellence was very proud to organise this scientific symposium which explored both clinical and research aspects of Bone Marrow Biology, acquired and inherited Bone Marrow Failure Syndromes.